Hutchings P R, Cooke A, Dawe K, Waldmann H, Roitt I M
Immunology Department, University College and Middlesex Medical School, London.
Eur J Immunol. 1993 Apr;23(4):965-8. doi: 10.1002/eji.1830230431.
Treatment with a non-depleting monoclonal antibody to CD4 in the presence of mouse thyroglobulin (MTg) inhibits the development of murine autoimmune thyroiditis. This unresponsiveness was transferrable since such treatment generated a population of donor cells which could suppress the thyroiditis induced in lightly irradiated recipients by subsequent challenge with specific antigen. The suppression appears to be both antigen specific and antigen dependent and seems to discriminate between TH1 and TH2 helper subsets in that there is no significant effect on anti-MTg autoantibodies after challenge.
在小鼠甲状腺球蛋白(MTg)存在的情况下,用非耗竭性抗CD4单克隆抗体进行治疗可抑制小鼠自身免疫性甲状腺炎的发展。这种无反应性是可转移的,因为这种治疗产生了一群供体细胞,这些细胞可以抑制轻度辐照受体在随后受到特异性抗原攻击时诱发的甲状腺炎。这种抑制似乎既是抗原特异性的,也是抗原依赖性的,并且似乎能够区分TH1和TH2辅助亚群,因为在攻击后对抗MTg自身抗体没有显著影响。